News Search Results
Oct 15, 2025, 07:00 ET Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations
More news about: Bio-Techne Corporation
Oct 14, 2025, 10:30 ET Molecular Cytogenetics Market worth $1.43 billion in 2030 7.1% CAGR | MarketsandMarkets™
Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Abbott (US), Agilent Technologies, Inc. (US), PacBio (US), Bio-Rad Laboratories, Inc. (US), and Bio-Techne (US), among others. Danaher (US) In 2024, SomnoMed ranked
More news about: MarketsandMarkets
Oct 09, 2025, 07:00 ET Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Oct 07, 2025, 10:01 ET Multi-Plex Immunoassays Market to Reach US$ 6.90 Billion by 2033 as Precision Medicine and Biomarker Discovery Fuel Global Adoption | DataM Intelligence
biopsy. BD & Bio-Techne Both companies are expanding multiplex solutions for immuno-oncology, with BD leading in hospital adoption and Bio-Techne in translational research.
More news about: DataM Intelligence 4 Market Research LLP
Sep 26, 2025, 06:30 ET Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
in diagnostic procedures. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Sep 24, 2025, 06:59 ET Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
market-based greenhouse gas emissions. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Sep 19, 2025, 10:30 ET In Vitro Diagnostics (IVD) Quality Control Market worth $2.15 billion by 2030 with 5.5% CAGR | MarketsandMarkets™
providing laboratories and blood banks worldwide with greater choice from a single supplier. In November 2024, Bio-Techne Corporation (US) obtained In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators, confirming
More news about: MarketsandMarkets
Sep 15, 2025, 10:45 ET Immunohistochemistry Market worth US$5.14 billion by 2030 with 7.6% CAGR | MarketsandMarkets™
Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Bio-Techne (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), PHC Holdings Corporation (Japan),
More news about: MarketsandMarkets
Sep 09, 2025, 07:00 ET ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Sep 04, 2025, 11:42 ET MSC-Specific Cell Culture Medium Market to Reach USD 4.1 Billion by 2035, with CAGR 11.6% Driven by Regenerative Medicine and Stem Cell Therapy Growth
ScientificLonza GroupMerck KGaASartorius AGCorning IncorporatedPromoCell GmbHSTEMCELL TechnologiesBio-Techne CorporationFUJIFILM Irvine ScientificHiMedia LaboratoriesTo Know an Additional List of Key Players, Request Here
More news about: Vantage Market Research
Aug 27, 2025, 07:00 ET Bio-Techne to Present at Upcoming Investor Conferences
https://investors.bio-techne.com/ir-calendar. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Aug 26, 2025, 17:46 ET Global Digital Biomarkers Market Anticipating Remarkable Growth at a CAGR of ~17% by 2032 | DelveInsight
including Abbott, Merck KGaA, Quanterix, Bio-Rad Laboratories, Inc., Banyan Biomarkers, Inc., Quanterix, Thermo Fisher Scientific, Fujirebio, Bio-Techne, ADx NeuroSciences NV, F. Hoffmann-La Roche Ltd., BIOMÉRIEUX, Siemens Healthineers, Quibim, C₂N Diagnostics, among others.
More news about: DelveInsight Business Research, LLP
Aug 14, 2025, 07:00 ET ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Aug 06, 2025, 06:30 ET BIO-TECHNE DECLARES DIVIDEND
considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological
More news about: Bio-Techne Corporation
Aug 06, 2025, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
included in this press release. "Bio-Techne delivered a solid fourth quarter that was in-line with our expectations, despite ongoing market uncertainty," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "We achieved strong performance in our
More news about: Bio-Techne Corporation
Aug 05, 2025, 16:30 ET Bio-Techne Announces Exosome Diagnostics Divestiture
emphasis on these statements. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Aug 05, 2025, 10:45 ET Cell Culture Market to Reach USD 71.1 Billion by 2032, Says SkyQuest Technology Consulting
SELonzaGetinge AB (Sweden)Agilent Technologies Inc.HiMedia LaboratoriesBio-TechneMiltenyi BiotecSTEMCELL TechnologiesSolida Biotech GmbHCaisson Labs Inc.PromoCell GmbHInvivoGenPan-BiotechSecure
More news about: SkyQuest Technology
Aug 05, 2025, 07:00 ET ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jul 31, 2025, 10:30 ET Cell Culture Market worth US$50.69 billion by 2030 with 11.2% CAGR | MarketsandMarkets™
(Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US). Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific is
More news about: MarketsandMarkets
Jul 31, 2025, 07:00 ET ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson
More news about: Bio-Techne Corporation
Jul 28, 2025, 08:30 ET Global Momentum and Validation Grows at AAIC for ALZpath Proprietary pTau217 Antibody Use in Alzheimer's Disease Research, Diagnosis, and Treatment
treatment and monitoring. Through licensing agreements with industry leaders – including Beckman Coulter Diagnostics, Roche, Alamar Biosciences, Bio-techne, and Quanterix – ALZpath is accelerating the development of new medicines and expanding access to early diagnosis and monitoring. Additionally, ALZpath
More news about: ALZpath, Inc.
Jul 25, 2025, 12:13 ET Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030
include: AGILENT TECHNOLOGIES INC. ARRAYIT CORP. BIO-RAD LABORATORIES INC. BIO-TECHNE BRUKER CREATIVE PROTEOMICS DANAHER CORP. JEOL LTD. MERCK KGAA PROMEGA
More news about: BCC Research LLC
Jul 25, 2025, 09:07 ET Spear Bio Launches Next Generation Ultrasensitive Immunoassay Solution SPEAR UltraDetect™ to Transform Neurodegenerative Disease Research
Bio-Techne to distribute SPEAR UltraDetect immunoassays globally.
More news about: Spear Bio
Jul 17, 2025, 07:00 ET Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
Saturday, September 6, 2025. About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into
More news about: Bio-Techne Corporation
Jul 15, 2025, 07:00 ET Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
Learn more about Spear Bio and Bio-Techne About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific
More news about: Bio-Techne Corporation